Bridge Builder Small/Mid Cap Growth Fund (BBGSX)

NASDAQ · Mutual Fund · Delayed Price · Currency is USD
16.76
-0.10 (-0.59%)
May 19, 2026, 4:00 PM EST
Fund Assets10.12B
Expense Ratio0.36%
Min. Investment$0.00
Turnover74.00%
Dividend (ttm)1.17
Dividend Yield7.07%
Dividend Growth1,180.32%
Payout FrequencySemi-Annual
Ex-Dividend Daten/a
Previous Close16.86
YTD Return3.50%
1-Year Return6.37%
5-Year Return13.78%
52-Week Low15.04
52-Week High18.06
Beta (5Y)1.05
Holdings1511
Inception DateApr 27, 2015

About BBGSX

Bridge Builder Small/Mid Cap Growth Fund is an open-end mutual fund focused on delivering long-term capital appreciation by investing primarily in the equity securities of small and mid-capitalization companies. The fund diversifies across a broad range of sectors, reflecting a portfolio with over 1,500 holdings, and allocates around 99% of its assets to U.S.-based companies. Its strategy seeks to tap into the growth potential characteristic of smaller companies, which can provide dynamic expansion opportunities within the market. Managed under the Bridge Builder Trust and established in 2015, the fund emphasizes annual dividend and capital gains distributions. With a relatively modest expense ratio and no sales loads, Bridge Builder Small/Mid Cap Growth Fund is positioned to serve investors looking for exposure to growth-oriented equities beyond large-cap stocks, providing a vehicle for participation in evolving and innovative segments of the domestic economy.

Fund Family Bridge Builder
Category Mid-Cap Growth
Performance Rating Average
Risk Rating Average
Stock Exchange NASDAQ
Ticker Symbol BBGSX
Index Russell 2500 Growth TR

Performance

BBGSX had a total return of 6.37% in the past year, including dividends. Since the fund's inception, the average annual return has been 10.25%.

Top 10 Holdings

13.44% of assets
NameSymbolWeight
JPMorgan U.S. Government Money Market FundMGMXX2.91%
Bloom Energy CorporationBE1.80%
Comfort Systems USA, Inc.FIX1.53%
RBC Bearings IncorporatedRBC1.36%
ASCENDIS PHARMA A/Sn/a1.21%
argenx SEARGX0.98%
West Pharmaceutical Services, Inc.WST0.95%
Astera Labs, Inc.ALAB0.93%
Insmed IncorporatedINSM0.90%
Credo Technology Group Holding LtdCRDO0.87%
View More Holdings

Dividend History

Ex-DividendAmountPay Date
Dec 26, 2025$0.02094Dec 29, 2025
Dec 19, 2025$1.17488Dec 22, 2025
Dec 27, 2024$0.0934Dec 30, 2024
Dec 27, 2023$0.04488Dec 28, 2023
Dec 27, 2022$0.02232Dec 28, 2022
Dec 27, 2021$0.01157Dec 28, 2021
Full Dividend History